Long-term outcome of patients treated with prophylactic nesiritide for the prevention of acute kidney injury following cardiovascular surgery

Clinical Cardiology

Volumn 33, Issue 4, 2010, Pages 217-221

  Lingegowda, Vijaykumar ^a   Van, Quoc C ^a   Shimada, Michiko ^b   Beaver, Thomas M ^a   Dass, Bhagwan ^a   Sood, Puneet ^a   Ejaz, A Ahsan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NESIRITIDE; PLACEBO;

ADULT; ARTICLE; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; INSTITUTIONAL REVIEW; KIDNEY FUNCTION; KIDNEY INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROPHYLAXIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SURVIVAL; TREATMENT DURATION;

AGED; CARDIOVASCULAR SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PLACEBOS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77950825061     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20750     Document Type: Article

References (28)

1. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int. 1994;45:1731-1738. (Pubitemid 24207509)
2. Allgren RL, Marbury TC, Rahman SN, et al; for Auriculin Anaritide Acute Renal Failure Study Group. Anaritide in acute tubular necrosis.N Engl J Med. 1997;336:828-834.
3. Swärd K, Valsson F, Odencrants P, et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial [published correction appears in Crit Care Med. 2006;34:1862]. Crit Care Med. 2004;32: 1310-1315.
4. Lewis J, Salem MM, Chertow GM, et al; for Anaritide Acute Renal Failure Study Group. Atrial natriuretic factor in oliguric acute renal failure. Am J Kidney Dis. 2000;36:767-774.
5. Beaver TM, Winterstein AG, Shuster JJ, et al. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol. 2006;29:18-24.
6. Ejaz AA, Martin TD, Johnson RJ, et al. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg. 2009;138:959-964.
7. Coca SG, Peixoto AJ, Garg AX, et al. The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis. 2007;50:712-720.
8. Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med. 2008;168: 609-616.
9. Mentzer RM Jr, Oz MC, Sladen RN, et al; for NAPA Investigators. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol. 2007;49:716-726.
10. Cooper WA, O'Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113:1063-1070. (Pubitemid 43754272)
11. Mehta RL, Kellum JA, Shah SV, et al; for Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11:R31.
12. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008;36:1129-1137. (Pubitemid 351482661)
13. Ishani A, Xue JL,Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223-228.
14. Davies MG, SaadWE, Peden EK, et al. Implications of acute functional injury following percutaneous renal artery intervention. Ann Vasc Surg. 2008;22:783-789.
15. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005;16:195-200.
16. Dyke CM, Bhatia D, Aronson S, et al. Perioperative nesiritide and possible renal protection in patientswithmoderate to severe kidney dysfunction. J Thorac Cardiovasc Surg. 2008;136:1369-1370.
17. Chen HH, Sundt TM, Cook DJ, et al. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation. 2007;116:1134-1138.
18. Aalberts JJ, Boonstra PW, van den Berg MP, et al. In-hospital mortality and three-year survival after repaired acute type A aortic dissection. Neth Heart J. 2009;17:226-231.
19. Tabayashi K, Sai S, Yoshida Y, et al. Thoracic aortic aneurysmectomy with a sutureless intraluminal ringed graft. Cardiovasc Surg. 1994;2:451-455. (Pubitemid 24244746)
20. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885-892. (Pubitemid 32202459)
21. Birkmeyer NJ, Marrin CA, Morton JR, et al; for Northern New England Cardiovascular Disease Study Group. Decreasing mortality for aortic and mitral valve surgery in Northern New England. Ann Thorac Surg. 2000;70:432-437.
22. Murday AJ, Hochstitzky A, Mansfield J, et al. A prospective controlled trial of St. Jude versus Starr Edwards aortic and mitral valve prostheses. Ann Thorac Surg. 2003;76:66-73. (Pubitemid 36819718)
23. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-1089. (Pubitemid 46673170)
24. Mangano DT, Miao Y, Vuylsteke A, et al; Investigators of The Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471-479.
25. Toumpoulis IK, Chamogeorgakis TP, Angouras DC, et al. Independent predictors for early and long-term mortality after heart valve surgery. J Heart Valve Dis. 2008;17:548-556.
26. Levy F, Laurent M, Monin JL, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51:1466-1472. (Pubitemid 351479228)
27. McCullough PA. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med. 2002;3:71-76.
28. Ponte B, Felipe C, Muriel A, Tenorio MT, Liaño F. Long-term functional evolution after an acute kidney injury: a 10-year study. Nephrol Dial Transplant. 2008;23:3859-3866. (Pubitemid 351486429)